WO2008097341A3 - Antiviral compounds and use thereof - Google Patents

Antiviral compounds and use thereof Download PDF

Info

Publication number
WO2008097341A3
WO2008097341A3 PCT/US2007/074478 US2007074478W WO2008097341A3 WO 2008097341 A3 WO2008097341 A3 WO 2008097341A3 US 2007074478 W US2007074478 W US 2007074478W WO 2008097341 A3 WO2008097341 A3 WO 2008097341A3
Authority
WO
WIPO (PCT)
Prior art keywords
antiviral compounds
compounds
pharmaceutical compositions
relates
viral infection
Prior art date
Application number
PCT/US2007/074478
Other languages
French (fr)
Other versions
WO2008097341A2 (en
Inventor
Kraig M Yager
In Chul Kim
David Gerrish
Mark Anderson
Original Assignee
Myriad Genetics Inc
Kraig M Yager
In Chul Kim
David Gerrish
Mark Anderson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc, Kraig M Yager, In Chul Kim, David Gerrish, Mark Anderson filed Critical Myriad Genetics Inc
Publication of WO2008097341A2 publication Critical patent/WO2008097341A2/en
Publication of WO2008097341A3 publication Critical patent/WO2008097341A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection.
PCT/US2007/074478 2006-07-26 2007-07-26 Antiviral compounds and use thereof WO2008097341A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82043006P 2006-07-26 2006-07-26
US60/820,430 2006-07-26

Publications (2)

Publication Number Publication Date
WO2008097341A2 WO2008097341A2 (en) 2008-08-14
WO2008097341A3 true WO2008097341A3 (en) 2008-10-30

Family

ID=39682261

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/074478 WO2008097341A2 (en) 2006-07-26 2007-07-26 Antiviral compounds and use thereof

Country Status (1)

Country Link
WO (1) WO2008097341A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS54239B1 (en) 2010-06-04 2015-12-31 Bristol-Myers Squibb Company C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053255A2 (en) * 2004-11-12 2006-05-18 Panacos Pharmaceuticals, Inc. Novel betulin derivatives, preparation thereof and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053255A2 (en) * 2004-11-12 2006-05-18 Panacos Pharmaceuticals, Inc. Novel betulin derivatives, preparation thereof and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUN ET AL.: "Anti-AIDS Agents 49. Synthesis, Anti-HIV, and Anti-Fusion Activities of IC9564 Analogues Based on Betulinic Acid", J. MED. CHEM., vol. 45, 2002, pages 4271 - 4275, XP002526217, DOI: doi:10.1021/JM020069C *

Also Published As

Publication number Publication date
WO2008097341A2 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
WO2008127364A3 (en) Antiviral compounds and use thereof
WO2008115281A3 (en) Compounds for treating viral infections
EP1865967A4 (en) Compounds, compositions and methods for the treatment of viral infections and other medical disorders
HK1113085A1 (en) Compounds, compositions and methods for the treatment of poxvirus infections
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
WO2009129246A3 (en) Compositions and methods for preparing and using same
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
WO2009156462A3 (en) Organic compounds
WO2008113011A3 (en) Virus like particle purification
AU2005235116A1 (en) Combinations for treating HIV infection
WO2008017346A3 (en) Ascorbic acid derivatives, use thereof for the functionalization of matrices
WO2008153610A3 (en) Use of il-23 antagonists for treatment of infection
BRPI0820162A2 (en) compound, pharmaceutical composition, method for prophylaxis or treatment of HIV infection or for prophylaxis, treatment or delay in the onset of AIDS
WO2007041632A3 (en) Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection
WO2008027600A3 (en) Imatinib compositions
WO2008073982A3 (en) 5,6-dihydro-1h-pyridin-2-one compounds
WO2006110831A3 (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
WO2009071689A3 (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2010052559A8 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
WO2009002538A3 (en) Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07872720

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07872720

Country of ref document: EP

Kind code of ref document: A2